·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹ Q&A
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊ½ºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
´º½º
English
ÆÊTV
¿ÀÇǴϾð
ÆÊ¸®Äí¸£Æ®
DPºÎµ¿»ê
TVÆÊµµ¶ó
ÆÊ¾ÆÄ«µ¥¹Ì
ÆÊ½ºÅ¸Å¬·´
µ¥Àϸ®ÆÊ¸Ê
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
ÆÊÆ÷ÀÎÆ®
MY ÆÊÆ÷ÀÎÆ®
Q&A
»óǰ ½ÅûȮÀÎ
³» Æ÷ÀÎÆ®
ÃÑ Àû¸³
0P
ÀÌ¿ë
0P
»ç¿ë°¡´É
0P
¹øÈ£
±¸ºÐ
Á¦¸ñ
³¯Â¥
23
´ç÷ÀÚ ¹ßÇ¥
8¿ù ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.09.03
22
´ç÷ÀÚ ¹ßÇ¥
7¿ù ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.08.01
20
´ç÷ÀÚ ¹ßÇ¥
6¿ù ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.07.02
19
´ç÷ÀÚ ¹ßÇ¥
5¿ù ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.06.01
14
´ç÷ÀÚ ¹ßÇ¥
4¿ù ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.05.02
13
´ç÷ÀÚ ¹ßÇ¥
[µ¥Àϸ®ÆÊ]ÆÊÆ÷ÀÎÆ® À̺¥Æ® ´ç÷ÀÚ
2018.04.16
12
´ç÷ÀÚ ¹ßÇ¥
3¿ù ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.04.02
10
´ç÷ÀÚ ¹ßÇ¥
2¿ù ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.03.02
9
´ç÷ÀÚ ¹ßÇ¥
[2018.1.31] ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.02.02
8
´ç÷ÀÚ ¹ßÇ¥
[2017.12.31] ÆÊÆ÷ÀÎÆ® ´ç÷ÀÚ
2018.01.02
<
6
7
8
9